SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kathleen who wrote (219)6/28/1998 10:24:00 PM
From: Gerald Underwood   of 857
 
Kathleen,

Thanks for the link.

I was previously unaware that the UK also was preparing to conduct multi-center trials until I ran across this
info at:
ndirect.co.uk
From the info on this site, apparently S. Africa as well as Belgium are also going to be conducting trials.

Does anyone know how many additional patients the FDA allowed into the latest cost recovery expansion in
the US for Ampligen?

Best,

Gerry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News